Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-81.94	13.26	73.40
Graham Fair Price	35.22	19237.85	14226.93
PEG	-81.81	0.04	-0.22
Price/Book	-1.61	0.36	0.37
Price/Cash Flow	-60.03	6.98	17.47
Prices/Earnings	-44.02	3.13	5.59
Price/Sales	9.27	0.84	0.77
Price/FCF	-60.03	6.98	17.47
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	104.09	0.15	0.07
Operating Margin	2664.02	0.08	< 0.005
ROA	77.29	0.02	0.01
ROE	0.02	0.03	75.76
ROIC	< 0.005	0.02	843.23
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	51.47
Dividends QOQ	0.00	-1.00	-100.00
EBIT QOQ	-1.06	26.38	2399.32
EPS QOQ	-0.26	0.79	207.71
FCF QOQ	2.29	1.51	-33.88
Revenue QOQ	< 0.005	-0.08	-1613.24
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	71.01	76.73	8.05
Days Sales Outstanding (DSO)	41.75	47.47	13.72
Inventory Turnover	1.27	1.17	-7.45
Debt/Capitalization	0.24	0.23	-1.67
Quick Ratio	0.48	0.60	24.99
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	23431.88	23899.41	2.00
Cash	837.81	2094.04	149.94
Capex	-267.36	-50.16	81.24
Free Cash Flow	491.60	1234.34	151.09
Revenue	11196.83	10282.88	-8.16
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.17	1.22	4.59
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	31.26	4.93	-84.23
Naive Interpretation	Member

06 - Financial Health · Weak

Rating